rnhale Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Latest Deal Amount
  • $1.76K

  • Investors
  • 4

rnhale General Information

Description

Developer of inhaled ribonucleic acid therapeutics designed to treat chronic obstructive pulmonary disease and severe asthma through local delivery to the lungs. The company offers RNA-loaded lipid nanoparticles formulated as inhalable dry powder, enabling improved stability, deep lung deposition, and cellular uptake for locally acting respiratory therapies.

Contact Information

Website
www.rnhale.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Am Klopferspitz 19
  • 82152 Planegg
  • Germany
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Pharmaceuticals
Vertical(s)
Nanotechnology, Life Sciences
Corporate Office
  • Am Klopferspitz 19
  • 82152 Planegg
  • Germany

rnhale Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

rnhale Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 01-Jan-2026 $1.76K Completed Pre-Clinical Trials
3. Grant 01-Apr-2025 Completed Pre-Clinical Trials
2. Accelerator/Incubator 01-Apr-2025 Completed Pre-Clinical Trials
1. University Spin-Out 01-Jan-2023 Completed Pre-Clinical Trials
To view rnhale’s complete valuation and funding history, request access »

rnhale Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

rnhale Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Science4Life Accelerator/Incubator
European Innovation Council Accelerator/Incubator
MAxL Accelerator/Incubator
Ludwig Maximilians University University
To view rnhale’s complete investors history, request access »

Ready to get started?

Request a free trial

rnhale FAQs

  • When was rnhale founded?

    rnhale was founded in 2023.

  • Where is rnhale headquartered?

    rnhale is headquartered in Planegg, Germany.

  • What is the size of rnhale?

    rnhale has 8 total employees.

  • What industry is rnhale in?

    rnhale’s primary industry is Biotechnology.

  • Is rnhale a private or public company?

    rnhale is a Private company.

  • What is rnhale’s current revenue?

    The current revenue for rnhale is .

  • How much funding has rnhale raised over time?

    rnhale has raised $1.76K.

  • Who are rnhale’s investors?

    Science4Life, European Innovation Council, MAxL, and Ludwig Maximilians University have invested in rnhale.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process